IRF5 and systemic lupus erythematosus: IRF5 contribution to SLE disease can be explained by the fact that its protein product functions as a transcriptional factor which activates cytokines such as IL-6, IL-12, and TNF-α via the activation of Toll-like receptor signaling pathway [16].